Comment from Kanevsky Alex

I am submitting this comment to share my personal experience with BPC-157 and TB-500. I understand these peptides are intended to be used responsibly, with appropriate medical oversight, and not as products for casual or unsupervised use. In my own experience, when used as part of a comprehensive treatment plan that also included proper rehabilitation, nutrition, and lifestyle modifications, these peptides played a meaningful role in my recovery. They were not a substitute for healthy habits or professional care, but rather one component of a broader strategy. I experienced significant improvements in my recovery process without adverse effects. While I recognize that my experience is anecdotal and should not be interpreted as proof of effectiveness for everyone, I believe patient experiences have value alongside scientific research when regulatory decisions are being considered. I encourage the FDA to evaluate these peptides based on the totality of the available evidence, including preclinical and clinical research, safety data, and real-world patient experiences. Restricting access to compounds that many patients and healthcare professionals have found beneficial may limit valuable therapeutic options for individuals seeking to recover from injuries and improve quality of life under appropriate medical supervision. Thank you for considering my comments as part of the public record.